Physician profile
John P Spirnak
NPI 1295724136
$364.88
in general payments reported to CMS, 2019-2025
11 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.62 · 2022: $26.03 · 2023: $17.53 · 2024: $149 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267 · Education: $53.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.39 |
| Education | $53.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $68.18 | 2025 | Imfinzi, Lynparza |
| Laborie Medical Technologies Corp. | $59.73 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Verity Pharmaceuticals INC. | $57.22 | 2022-2025 | Trelstar |
| Boston Scientific Corporation | $54.88 | 2020-2024 | Ams 700 |
| Dendreon Pharmaceuticals LLC | $34.97 | 2024 | Provenge |
| Abbvie INC. | $17.53 | 2023 | Botox |
| Calyxo, INC. | $15.19 | 2024 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $15.13 | 2024 | |
| Blue Earth Diagnostics | $15.02 | 2024 | |
| Sun Pharmaceutical Industries INC. | $13.77 | 2022 | |
| Sumitomo Pharma America, INC. | $13.26 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Spirnak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.